Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chinese Middle Class Shuns Western Drugs In Favor Of Traditional Medicine (China)

This article was originally published in PharmAsia News

Executive Summary

Western drug makers are finding China's middle class a tough sell even though Chinese in that group are fans of U.S. cars and Starbucks. They still confine their drug spending to an average $10 a year, compared with the $900 American average. The Chinese middle class is as large as the entire U.S. population, but drug makers who have invested more than $1 billion in China the past 15 years have had little success in cracking the Chinese preference for traditional local medicine based on ingredients in plants. China also prohibits direct-to-consumer advertising for prescription drugs. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC065924

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel